Search Results - "Alkabbani, Wajd"

Adverse events associated with sodium glucose co-transporter 2 inhibitors: an overview of quantitative systematic reviews by Pelletier, Ryan, Ng, Kelvin, Alkabbani, Wajd, Labib, Youssef, Mourad, Nicolas, Gamble, John-Michael

“…Background: Multiple published quantitative systematic reviews have reported on adverse events associated with the use of sodium glucose co-transporter 2…”
Get full text

Cannabis is legal—why are cannabis-based pharmaceuticals still controlled? by Alkabbani, Wajd, Friesen, Kevin, Bugden, Shawn

Get full text

Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections: A Propensity Score–matched Population-based Cohort Study by Alkabbani, Wajd, Zongo, Arsène, Minhas-Sandhu, Jasjeet K., Eurich, Dean T., Shah, Baiju R., Alsabbagh, Mhd Wasem, Gamble, John-Michael

“…OBJECTIVESSodium-glucose cotransporter-2 (SGLT2) inhibitor-induced glycosuria is hypothesized to increase the risk of urinary tract infections (UTIs). We…”
Get full text

Use of Potentially Inappropriate Medications among Older Adults with Dementia or Cognitive Impairment Attending Memory Clinics: A Protocol for a Systematic Review and Meta-Analysis by Sharma, Rishabh, Gill, Jasdeep Kaur, Carter, Caitlin, Alkabbani, Wajd, Chhabra, Manik, Vidyasagar, Kota, Chang, Feng, Lee, Linda, Patel, Tejal

“…Abstract Introduction: Older adults with dementia who are on multiple medications are more vulnerable to the use of potentially inappropriate medications…”
Get full text

The association of sodium‐glucose cotransporter 2 inhibitors with cancer: An overview of quantitative systematic reviews by Pelletier, Ryan, Ng, Kelvin, Alkabbani, Wajd, Labib, Youssef, Mourad, Nicolas, Gamble, John‐Michael

“…Aims To summarize reported cancer events associated with SGLT‐2 inhibitors used in patients with type 2 diabetes mellitus, as well as assess the quality of…”
Get full text

756-P: Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Endoscopy Failure or Aspiration-A Cohort Study by Alkabbani, Wajd, Suissa, Karine, Gu, Kristine D

“…Introduction & Objective: Several cases of aspiration during endoscopy have been reported in glucagon-like peptide-1 receptor agonists (GLP1RA) users due to…”
Get full text

Authors’ Reply to Noguchi’s comment on: “Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data.” by Gamble, John-Michael, Alkabbani, Wajd

Get full text

Pioglitazone and Lower Risk of Dementia: Will This Change Practice? by Maxwell, Colleen J., Alkabbani, Wajd, Yasar, Sevil

Get full text

Comment on: "Drug–Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data"/Authors' Reply to Noguchi's comment on: "Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data." by Noguchi, Yoshihiro, Gamble, John-Michael, Alkabbani, Wajd

“…[...]I reanalyzed using the Q shrinkage measure from the raw data in Tables 2 and 3 of the original paper. [...]the 95% CIs for the age- and sex-adjusted ROR…”
Get full text

Pioglitazone and Lower Risk of Dementia: Will This Change Practice? by Maxwell, Colleen J., Alkabbani, Wajd, Yasar, Sevil

Get full text

Author’s Reply to Kuss and Rathmann’s Comment on: “Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data” by Gamble, John-Michael, Alkabbani, Wajd

Get full text

Comment on "Drug-Drug Interaction of the Sodium Glucose Co-Transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data"/Author's Reply to Kuss and Rathmann's Comment on: "Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data" by Kuss, Oliver, Rathmann, Wolfgang, Gamble, John-Michael, Alkabbani, Wajd

Get full text

Active‐comparator restricted disproportionality analysis for pharmacovigilance signal detection studies of chronic disease medications: An example using sodium/glucose cotransporter 2 inhibitors by Alkabbani, Wajd, Gamble, John‐Michael

“…Aims Disproportionality analysis is a common pharmacovigilance tool to detect safety signals of type 2 diabetes medications from spontaneous drug reporting…”
Get full text

999-P: Trends and Characteristics of Continuous Glucose Monitoring Initiation in Older Adults with Diabetes-A Cohort Study by Alkabbani, Wajd, Paik, Julie M, Kim, Dae H, Munshi, Medha, Wexler, Deborah J, Patorno, Elisabetta

“…Introduction & Objective: The use of continuous glucose monitoring (CGM) devices improves glycemic outcomes and minimizes hypoglycemia in older adults with…”
Get full text

Sodium/Glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis: An Example of Complementary Evidence for Rare Adverse Events by Alkabbani, Wajd, Pelletier, Ryan, Gamble, John-Michael

“…Evidence from observational studies may be considered complementary to that of randomized controlled trials (RCTs), particularly when assessing rare outcomes…”
Get full text

Drug–Drug Interaction of the Sodium Glucose Co-Transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data by Alkabbani, Wajd, Pelletier, Ryan, Beazely, Michael A., Labib, Youssef, Quan, Breanna, Gamble, John-Michael

“…Introduction An increased risk of myopathy due to a potential interaction between sodium glucose co-transporter-2 inhibitors (SGLT-2i) and HMG-CoA reductase…”
Get full text

Prevalence of Potentially Inappropriate Medications in Older Adults with Cognitive Impairment or Dementia Attending Memory Clinics: A Systematic Review and Meta-Analysis by Sharma, Rishabh, Gill, Jasdeep Kaur, Chhabra, Manik, Carter, Caitlin, Alkabbani, Wajd, Vidyasagar, Kota, Chang, Feng, Lee, Linda, Patel, Tejal

“…Older adults with dementia who are on polypharmacy are more vulnerable to the use of potentially inappropriate medications (PIM), which can significantly…”
Get more information

Peak performance: Putting type 1 diabetes management recommendations for athletes to the test by Grightmire, Bradley, Alkabbani, Wajd, Gamble, John-Michael

“…Athletes with type 1 diabetes (T1D) face unique challenges to maintain optimal glucose levels and therefore require tailored guidance from their healthcare…”
Get full text

Trends in estimated total retail dispensed prescriptions of purported COVID-19 treatments and preventions in Canada by Alkabbani, Wajd, Gamble, John-Michael

“…Abstract Objectives Several medications were proposed for the treatment and prophylaxis of COVID-19 but with limited supporting evidence. Herein, we assessed…”
Get full text

Associations of Mid- and Late-Life Severe Hypoglycemic Episodes With Incident Dementia Among Patients With Type 2 Diabetes: A Population-Based Cohort Study by Alkabbani, Wajd, Maxwell, Colleen J, Marrie, Ruth Ann, Tyas, Suzanne L, Lega, Iliana C, Gamble, John-Michael

“…Severe hypoglycemia is associated with an increased risk of dementia. We examined if the association is consistently present in mid- and late-life…”
Get full text